Maha Abdel-Kader
Psychiatry · Manassas, VANPI 1730172065
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,510 and has fallen 76.2% since, to $359 in 2025.
Across 145 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$415
- Takeda Pharmaceuticals U.S.A., Inc.$319
- Supernus Pharmaceuticals, Inc.$287
- Lundbeck LLC$227
- Sunovion Pharmaceuticals Inc.$173
- Neos Therapeutics, LP$148
- plus $802 from 15 others
What the payments were for
- Food & beverage$2,371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $415 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $319 |
| Supernus Pharmaceuticals, Inc. | 16 | $287 |
| Lundbeck LLC | 13 | $227 |
| Sunovion Pharmaceuticals Inc. | 17 | $173 |
| Neos Therapeutics, LP | 8 | $148 |
| Otsuka America Pharmaceutical, Inc. | 12 | $146 |
| Ironshore Pharmaceuticals Inc. | 4 | $142 |
| Johnson & Johnson | 4 | $100 |
| Shire North American Group Inc | 3 | $64 |
| Bausch Health US, LLC | 3 | $59 |
| Tris Pharma Inc | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $53 |
| Neurocrine Biosciences, Inc. | 3 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| TMS Neurohealth Centers Inc. | 1 | $29 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $13 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Alfasigma USA, Inc. | 1 | $11 |
How this compares
$2,371 in reported general payments places this provider in the 85th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 14 | $5,416 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 42 | $1,542 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 29 | $1,336 |
| Bupropion XlBupropion Hcl | 31 | $762 |
| Clonazepam | 47 | $423 |
| Trazodone Hcl | 45 | $323 |
| Duloxetine Hcl | 19 | $316 |
| Lamotrigine | 25 | $297 |
| Gabapentin | 20 | $245 |
| Fluoxetine Hcl | 30 | $229 |
| Alprazolam | 39 | $199 |
| Amitriptyline Hcl | 14 | $186 |
| Zolpidem Tartrate | 18 | $136 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $121 |
| Escitalopram Oxalate | 19 | $118 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Manassas
- Jasdeep MiglaniManassas$958K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- David SpiegelNorfolk$565K
- William YetterVirginia Beach$312K
- Anita ClaytonCharlottesville$260K
- Robert GardellaStaunton$201K
- Timothy KaneStaunton$162K
- Ralph McKenzieRoanoke$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.